SCHEDULE DETAILS Information of Event Schedules

World is committed to making participation in the event a harassment free experience for everyone, regardless of level of experience, gender, gender identity and expression

2.30 - 3.30 PM Seminar
Head & Neck

Dr. Maha Idrresi

Head & Neck

Head & Neck

3.30 - 4.30 PM Workshop
NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

DR. SHAKIR SHAKIR

NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

NRG-RTOG 1016: Phase III Trial Comparing Radiation/Cetuximab to Radiation/Cisplatin in HPV-related Cancer of the Oropharynx

4.30 - 5.30 PM Seminar
GI Cancers

Dr. Belal Moftah

GI Cancers

GI Cancers

6.30 - 7.30 PM Workshop
A Prospective Study Assessing Early Cardiotoxicity after Trimodality Therapy for Esophageal Cancer

Dr. Hassan Abdullah

A Prospective Study Assessing Early Cardiotoxicity after Trimodality Therapy for Esophageal Cancer

A Prospective Study Assessing Early Cardiotoxicity after Trimodality Therapy for Esophageal Cancer

5.30 - 6.30 PM Seminar
Questions & Discussion

Dr. Reem AlOmran

Questions & Discussion

Questions & Discussion

09.00 - 11.30 AM Workshop
 Opening Remarks

Dr. Yasser Bayoumi

Opening Remarks

Opening Remarks

9.30 - 10.30 AM Seminar
 Breast cancer

Dr. Omar Lskandrani

Breast cancer

Breast cancer

10.30 - 11.30 AM Workshop
 Randomized Trial Evaluating Radiation following Surgical Excision for “Good Risk” DCIS: 12-Year Report from NRG/RTOG 9804

Dr. Reem AlOmran

Randomized Trial Evaluating Radiation following Surgical Excision for “Good Risk” DCIS: 12-Year Report from NRG/RTOG 9804

Randomized Trial Evaluating Radiation following Surgical Excision for “Good Risk” DCIS: 12-Year Report from NRG/RTOG 9804

12.30 - 01.30 PM Workshop
 Gynecological & GU Cancer

Dr. Maha Idrresi

Gynecological & GU Cancer

Gynecological & GU Cancer

10.30 - 11.30 AM Workshop
 A Prospective Study of IMRT Versus 3D-CRT for Post-Operative Cervical Cancer Patients.

Dr. Yasser Bayoumi

A Prospective Study of IMRT Versus 3D-CRT for Post-Operative Cervical Cancer Patients.

A Prospective Study of IMRT Versus 3D-CRT for Post-Operative Cervical Cancer Patients.

HURRY UP! Book your Seat

SUBSCRIBE TO NEWSLETTER

Want Something Extra?